Company search
Overview
Performance
Portfolio
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Portfolio yield
Data as at : 30/06/2026
| % |
|---|
| 0.1 |
Please note that the above fields are displayed for companies that have reported this data to the AIC. Where data is reported, it may be subject to valuation lags.
Top holdings
Data as at : 31/05/2026
| Investment | % of total assets |
|---|---|
| Insmed Inc | 4.6 |
| Madrigal Pharmaceuticals Inc | 4.4 |
| Vera Therapeutics Inc Class A | 4.1 |
| Travere Therapeutics Inc Ordinary Shares | 3.8 |
| Alnylam Pharmaceuticals Inc | 3.7 |
| Crinetics Pharmaceuticals Inc | 3.6 |
| Vertex Pharmaceuticals Inc | 3.3 |
| Cytokinetics Inc | 3.2 |
| Revolution Medicines Inc Ordinary Shares | 3.2 |
Geographic breakdown
Data as at : 30/06/2026
| Country | % of total assets |
|---|---|
| USA | 71.6 |
| UK | 9.5 |
| Cayman Islands | 2.6 |
| Netherlands | 2.5 |
| Denmark | 2.3 |
| Canada | 1.4 |
| Guernsey | 1.2 |
| Singapore | 1.1 |
| France | 0.6 |
| China | 0.1 |
Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.
Industry breakdown
Data as at : 31/05/2026
| Industry | % of total assets |
|---|---|
| Healthcare | 91.8 |
| Cash Equivalents | 7.7 |
| Preferred | 0.0 |
| Government Related | -6.4 |
Scroll
Asset breakdown
Data as at : 31/05/2026
| Asset | % of total assets |
|---|---|
| Stock | 98.7 |
| Bond | -6.4 |
| Cash/Cash equivalents | 7.7 |
Detailed asset breakdown
Data as at : 31/05/2026
| Asset | % of total assets |
|---|---|
| North America - stock | 83.9 |
| Other - stock | 8.6 |
| Cash | 7.7 |
| Asia (excl Japan) - stock | 2.1 |
| Europe - Mid-cap stock | 1.7 |
| UK - Small growth stock | 1.5 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
